Cathie Wood’s ARK Invest Sells Over 840,000 Shares of Seres Therapeutics

One of Cathie Wood's ARK Invest exchange-traded funds sold over 840,000 shares of Seres Therapeutics on August 30.

Published August 31, 2021, 8:35am ET · 1 min read

A gloved hand holds a luminous test tube containing a green leaf, surrounded by glowing hexagonal chemical structures and scientific symbols against a dark, gradient background fading from blue to green. The scene evokes scientific research and innovation.
Scientific research and pharmaceutical innovation, like those at Eli Lilly, are critical drivers of future growth. Advances in biotechnology are poised to unlock significant market value. © SergeyNivens / Getty Images

One of the ARK Invest exchange-traded funds run by ETF star Cathie Wood sold over 840,000 shares of Seres Therapeutics Inc. (NASDAQ: MCRB) shares on Monday, as the price of this ETF was up nearly 1% in Monday’s session. The fund is up significantly in the past year.

ARK Innovation ETF (NYSEARCA: ARKK) sold 846,468 shares of Seres Therapeutics. At Monday’s closing price, this would have valued this sale at roughly $5.2 million. This is only a small fraction of the total holdings. This ETF is up 35% over the past 52 weeks.

Here are all the ARK Invest sales on Monday:

Fund Ticker Name Shares
ARKF 6060HK ZHONGAN ONLINE P&C INSURANCE 981,100
ARKF 9923HK YEAHKA 297,200
ARKG PSTI PLURISTEM THERAPEUTICS 10,518
ARKG CLLS CELLECTIS 7,300
ARKG RHHBY ROCHE 78,900
ARKK MCRB SERES THERAPEUTICS 846,468
ARKK IOVA IOVANCE BIOTHERAPEUTICS 71,749
ARKQ ISRG INTUITIVE SURGICAL 1,700
ARKQ NXPI NXP SEMICONDUCTORS 13,000
ARKQ BABA ALIBABA 15,089
ARKQ GOOG ALPHABET 4,808
ARKW MELI MERCADOLIBRE 4,500
ARKW SE SEA 34,049

[nativounit]
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
[recirclink id=943923][wallst_email_signup]

Contact [email protected] for any questions or corrections.

Chris Lange

Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.

His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.

When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.

All articles →